Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

INV1166 CL

Diseases
Phomosis
Country
Germany
Registration Year
2018
Manufacturer
Bayer
No active offers.
Views
3
Reviews
0
Producer
Bayer
Description INV1166 CL
The winter rapeseed hybrid INV1166 CL from BASF is a high-yielding variety specifically developed for cultivation in various regions of Ukraine, including Polissia, Forest-Steppe, and Steppe. This hybrid is characterized by high yields reaching 45-50 c/ha, as well as good winter hardiness and drought resistance, ensuring stable and high-quality harvests even under challenging climatic conditions. The hybrid’s maturity group is early, allowing effective planning of agronomic activities and harvest timing.

INV1166 CL exhibits enhanced resistance to diseases, particularly phoma, due to the presence of the Rlm7 gene, significantly reducing yield losses and minimizing the need for chemical plant protection products. The hybrid is well-adapted to various soil types, including fertile and medium-fertility soils, and demonstrates high suitability for cultivation with minimal soil tillage, as well as early and late sowing. The recommended seeding rate is 450-500 thousand seeds per hectare.

In addition to high yield and disease resistance, the hybrid features excellent agronomic traits: high thousand-grain weight, high oil content, and resistance to lodging. These characteristics make INV1166 CL a reliable choice for farmers aiming to achieve high-quality and stable winter rapeseed yields with minimal inputs for crop maintenance and protection.
Specifications INV1166 CL
Diseases
Phomosis
Phomosis
Type of Rape
Winter rape
Hybrid Type
Simple Linear
Growing Season
90-100 days
Yield Potential
40-50 ц/га
Herbicide Resistance
Clearfield
Number of plants per hectare
400 thousand pcs/ha
500 thousand pcs/ha
Country
Germany
Registration Year
2018
Catalog
Varieties
Technical Crops
Manufacturer
Bayer
Where to buy INV1166 CL
Loading...
Reviews INV1166 CL
0comments
Sort by:Popular first
No comments yet.